(Q87442908)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24629494%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

The prognostic significance of Gleason scores in metastatic prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24629494%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Chad G Rusthoven

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24629494%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Julie A Carlson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24629494%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Timothy V Waxweiler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24629494%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Norman Yeh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24629494%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

David Raben

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24629494%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Thomas W Flaig

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24629494%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Brian D Kavanagh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24629494%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

12 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24629494%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24629494%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24629494%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24629494%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

707-713

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24629494%20AND%20SRC:MED&resulttype=core&format=json

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Metastatic Carcinoma of the Prostate: Identifying Prognostic Groups Using Recursive Partitioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Gleason score predicts androgen independent progression after androgen deprivation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Cancer progression after anterograde radical prostatectomy for pathologic Gleason score 8 to 10 and influence of concomitant variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Gleason score 7 prostate cancer treated with interstitial brachytherapy with or without supplemental external beam radiation and androgen deprivation therapy: is the primary pattern on needle biopsy prognostic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Gleason 5+4 has worse oncological and pathological outcomes compared with Gleason 4+5: significance of Gleason 5 pattern.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Impact of Age at Diagnosis on Outcomes in Men with Castrate-Resistant Prostate Cancer (CRPC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

A molecular signature predictive of indolent prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.004

10.1016/J.UROLONC.2014.01.004

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24629494%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference